Fesoterodine: a guide to its use in overactive bladder syndrome

Author：

ISSN： 1172-0360

Source： Drugs & Therapy Perspectives, Vol.26, Iss.1, 2010-01, pp. : 5-7

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Evaluation of fesoterodine fumarate for the treatment of an overactive bladder

By Mock Stephen Dmochowski Roger R

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 12, 2013-12 ,pp. : 1659-1666

Informa Healthcare

Access to resources Recommend Favorite

Tolterodine: A Review of its Use in the Treatment of Overactive Bladder

By Clemett D. Jarvis B.

Drugs & Aging, Vol. 18, Iss. 4, 2001-04 ,pp. : 277-304

Adis International

Access to resources Recommend Favorite

Solifenacin in Overactive Bladder Syndrome

By Payne Christopher K.

Drugs, Vol. 66, Iss. 2, 2006-01 ,pp. : 175-190

Adis International

Access to resources Recommend Favorite

Solifenacin in Overactive Bladder Syndrome

By Simpson Dene Wagstaff Antona J.

Drugs & Aging, Vol. 22, Iss. 12, 2005-01 ,pp. : 1061-1069

Adis International

Access to resources Recommend Favorite

Oxybutynin Extended-Release: A Review of its Use in the Management of Overactive Bladder

By Siddiqui M.A.A. Perry C.M. Scott L.J.

Drugs, Vol. 64, Iss. 8, 2004-01 ,pp. : 885-912

Adis International

Access to resources Recommend Favorite